Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Aug 5, 2026
Reporting period
Not applicable
Filed with the SEC
Aug 8, 2026
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001520262-26-000113
Filed / recorded
Aug 8, 2026, 1:17 AM UTC
Added to OQRO
Oct 6, 2026, 9:54 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Alkermes plc.
Issuer CIK
1520262
Ticker
ALKS
Reporting person
Blair Curtis Jackson
Relationship
Director, Officer
Officer title
President & CEO, Alkermes plc
Security
Employee Stock Option (Right to Buy)
Table
Derivative (Table II)
Transaction date
Aug 5, 2026
Transaction code
A
Shares / units
124,305
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
124,305
Ownership form
Direct
Amendment
No
Footnotes from the filing
This award was granted in connection with the reporting person's appointment as President and Chief Executive Officer.
Shares underlying the stock option shall vest and become exercisable, if at all, in two tranches based upon the closing price of an ordinary share of Alkermes plc, as reported by the Nasdaq Global Select Market or another national securities exchange on which Alkermes plc's ordinary shares are listed, trading at certain pre-specified levels for 30 consecutive trading days, subject in each case to the reporting person's completion of two years of continuous service (or less, in the event of a change in control) in the role of President and Chief Executive Officer. This award expires ten years from the date of grant.